François Rigenbach

Title: Innovations in Dermatological Treatments by François Rigenbach

Introduction

François Rigenbach is a notable inventor based in Bagneux, France. He has made significant contributions to the field of dermatology, particularly in the treatment of onychomycoses. His innovative approach has led to the development of a unique dermatological composition that enhances the effectiveness of antifungal agents.

Latest Patents

François Rigenbach holds a patent for the "Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions." This patent highlights the surprising discovery that hydrophilic penetration agents can improve the transcutaneous penetration of antifungal agents through nails. The composition includes antifungal agents from the allylamine family, such as terbinafine-HCl and naftifine-HCl, combined with various hydrophilic penetration agents and a suitable solvent medium.

Career Highlights

François Rigenbach is associated with Novartis AG, a leading global healthcare company. His work focuses on developing innovative solutions for dermatological conditions, showcasing his commitment to improving patient outcomes through scientific research and development.

Collaborations

Throughout his career, François has collaborated with esteemed colleagues, including Jean-Pierre Laugier and Marie-France Rude. These collaborations have contributed to the advancement of dermatological treatments and the sharing of knowledge within the field.

Conclusion

François Rigenbach's contributions to dermatology through his innovative patent demonstrate the potential for improved treatments for onychomycoses. His work continues to influence the field and offers hope for better patient care in dermatological practices.